Impact of paediatric malnutrition on sevoflurane requirements and recovery: A pilot study

Akhil K Singh1, Puneet Khanna1, Nitin Choudhary1

  • 1Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India.

Insights

Severe malnutrition in children significantly impacts anesthesia. Severely malnourished children experienced faster induction and prolonged emergence times with sevoflurane, suggesting MUAC can guide anesthetic planning.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Nutritional Science

Background:

  • Malnutrition affects anesthetic pharmacodynamics and pharmacokinetics in children.
  • Understanding these effects is crucial for optimizing pediatric anesthesia outcomes.

Purpose of the Study:

  • To assess the impact of varying malnutrition degrees on sevoflurane requirements.
  • To evaluate effects on induction and emergence times in children aged 2-9 years.

Main Methods:

  • Prospective observational study of 100 children (ASA I-II) undergoing short ophthalmic procedures.
  • Sevoflurane anesthesia was induced incrementally; induction/emergence times and requirements were recorded.
  • Nutritional status classified using CDC Z-scores; anthropometry (MUAC) measured.

Main Results:

  • Severely malnourished children had significantly faster induction (P < 0.05) and prolonged emergence.
  • Lower sevoflurane consumption was observed in severely malnourished children.
  • Mid-upper arm circumference (MUAC) strongly correlated with induction time, sevoflurane consumption, and emergence time in this group.

Conclusions:

  • Severe malnutrition significantly alters anesthetic response to sevoflurane.
  • MUAC shows potential as a practical indicator for anesthetic planning in malnourished children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
712
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
633